0
0.5
1
1.5
2+
Mortality
-8%
Improvement
Relative Risk
Hospitalization
18%
Mortality (b)
-19%
Hospitalization (b)
12%
HCQ for COVID-19 Alegiani et al. Prophylaxis
Is pre-exposure prophylaxis with HCQ beneficial for COVID-19?
Retrospective study in Italy
Lower hospitalization with HCQ (p=0.026)
c19hcq.org
Alegiani et al., Rheumatology, April 2021
Favors HCQ
Favors control